A SBIR Phase I contract was awarded to Affinergy in January, 2020 for $299,778.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in April, 2018 for $299,617.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in May, 2019 for $1,461,619.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in May, 2020 for $590,249.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in September, 2019 for $297,440.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in July, 2021 for $685,035.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in March, 2019 for $320,058.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in May, 2019 for $283,225.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in June, 2020 for $299,802.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in May, 2018 for $299,244.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in August, 2019 for $1,493,435.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in June, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in September, 2018 for $320,013.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Affinergy in April, 2021 for $294,541.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in September, 2018 for $2,276,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Affinergy in August, 2017 for $1,496,190.0 USD from the U.S. Department of Health & Human Services.